multi-kinase inhibitor LNK01002
Term · Oncology and biomedicine · MLC-T-ONC-015352
An orally bioavailable inhibitor of three as of yet undisclosed kinases, with potential antineoplastic activity. Upon oral administration, multi-kinase inhibitor LNK01002 inhibits the activity of the three as of yet undisclosed kinases. This may result in antitumor activity in tumor cells in which these kinases are upregulated or dysregulated.
| Identifier | MLC-T-ONC-015352 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | triple kinase inhibitor LNK01002 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015352",
"term": "multi-kinase inhibitor LNK01002",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable inhibitor of three as of yet undisclosed kinases, with potential antineoplastic activity. Upon oral administration, multi-kinase inhibitor LNK01002 inhibits the activity of the three as of yet undisclosed kinases. This may result in antitumor activity in tumor cells in which these kinases are upregulated or dysregulated.",
"synonyms": [
"triple kinase inhibitor LNK01002"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/multi-kinase-inhibitor-lnk01002/"
}
Record 11,414 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.